The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I take it our preferred partner will be Roche or B.ingelheim now with dreams of Kissei etc finished.
If NXP002 shows improved outcomes with Ofev and Esbriet then we can hope for a bidding war or two deals for combination therapy. Glad we have clarity on the path and I’m still hoping NXP004 is the one that gets us big money.
Mulder seems to be slipping out of character for a paid or shorting troll. Bit too much emotion for my liking and could direct him to other BB's like THG to brush up on his weaknesses. Normally you have be less hysterical and act like you have in-depth knowledge of the company.
Actually scrap that, after slipping up using multiple accounts, no polishing up on troll skills will gain an ounce of credibility.. I.e. stop wasting your time unless you get paid per post.
Let us know if you do?
A lot of companies lose money during growth and expenditure.
They don’t just magically becoming profitable from day 1. As we discussed Tesla is an example and Amazon would have been one for multiple years.
There are plenty that have gone on to be successful later even after a decade. The difficulty for everyone is predicting which ones will succeed in many years time to multi-bag and are making progress when the chips are down.
If we all wanted to invest in profitable companies we’d do this and collect dividends but most of us are taking a risk for bigger returns in the long run.
Psychology might be the biggest barrier to holding for many and these characters are here to prey on that.
I listen to both sides but I just wonder why you go on every share to spread a negative informative comment or go against any positivity. None of the shares you frequent have great news or are bullish when you turn up for some reason.
Is it because if your altruistic nature or is it because of you are part of the Winnifrith gang as somebody suggested.
I suspect you were also messaging Elon Musk about his failing growth company for a decade like all the other expert analysts because of the losses and debt.
I ain't no happy clapper but I can see an hidden agenda a mile off, as somebody of your accounting brilliance would not invest in all of these shares you engrossed in.
Fortune seems to think things will alright, even though I think elevated V prices is the only way to make the business more comfortable.
Going concern
Based on the current Group finances, having considered group budgets and cash flow forecasts, possible downside scenarios around commodity pricing and exchange rate and in particular around Vanchem's Kiln production profile, the cash flow forecasts demonstrate the Group will have sufficient headroom in its liquid resource to meet its obligations in the ordinary course of business for the next 12 months. Accordingly, the Directors continue to adopt the going concern basis in preparing the consolidated interim financial statements. This basis presumes that funds will be available to finance future operations and that the realisation of assets and settlement of liabilities, contingent obligations and commitments will occur in the ordinary course of business.
BE/Cellcube should look to build residential/small business VRFB's in SA as a starting point and worry about grid-storage later as their name develops. Eskom and SA government projects have too many hurdles and delays for a start and VRFB's are still unknown to the masses.
I'm hoping the mini-grid is the starting point for other miners to notice and also a significant reduction in production costs at Vametco.
I'm with you Steve, got majority of my PF in here but all the other shares recently are main listing or dividend yielding going forward. Learnt a lot from AIM investing in the past 4-5 years and will give it a wide berth once I have achieved fair value on this.
It's the market cap that is important Hippy but won't be long before it goes past that as well.
I am not giving fortune a free ride here as he could have performed a lot better, instead of having his fingers in too many pies.
However the pandemic has had a lot to answer for, because the timing was extremely bad for a growth story which requires a strong economy and lots of building.
Maybe US is still high but other areas are lower see Ryan’s note-
Moving on to the vanadium market, during H1 2022 the London Metal Bulletin ("LMB") Ferrovanadium price averaged US$45.0/kgV (H1 2021: US$33.4/kgV), Asian Metals prices Ferrovanadium prices averaged US$37.2/kgV (H1 2021: US$31.8/kgV) and US Ryan's Note prices averaged US$58.5/kgV (H1 2021: US$34.1/kgV)
Also-
US$8.5 million had been spent as at 30 June 2022, with most of the cost being Rand-denominated.
The Company forecasts a reduced capital expenditure rate from 2023 onwards, limited mainly to sustaining capital, which is expected to support positive cash conversion of EBITDA, particularly as the increased production volumes of Vanchem's Kiln 3 are realised.
Kiln3, court cases, building electrolyte plan, VRFB investment costs are hopefully in the past by the end of the year. It is time for BMN to main 5000MTV next year and pay off debts which will hopefully add the much needed rocket to the SP.
BE will be carved out and the BMN will become a simpler business to understand,
Calamari do you think the investing activity which accounts for a lot of the loss will now cease and operating costs will reduce with kiln 3 getting to full speed and therefore expenditure?
Do you think the Rand/dollar exchange rate at over 17.30 in favour of BMN will counteract some of the V price softening.
Don’t want to spoil your bad news story but for once some positive after a few bad years.